Previous 10 | Next 10 |
home / stock / vphif / vphif news
(NewsDirect) Valeo Pharma CEO Steve Saviuk joined Steve Darling from Proactive to share details about recent executive changes within the company. Saviuk announced the appointment of Pascal Tougas as the new chief financial officer, succeeding Luc Mainville. Tougas is recognized a...
VALEO PHARMA ANNOUNCES ORGANIZATIONAL CHANGES AND COST REDUCTION INITIATIVES Canada NewsWire Costs reduction initiatives and organizational realignment expected to generate annual savings exceeding $2 million . MONTREAL , Nov. 20, 2023 /CNW/ - V...
VALEO PHARMA ANNOUNCES APPOINTMENT OF MR. RICHARD LAJOIE TO BOARD OF DIRECTORS Canada NewsWire MONTREAL , Nov. 7, 2023 /CNW/ - Valeo Pharma Inc . (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " or the " Company "), a Canadian pharmaceutical company, t...
(NewsDirect) Valeo Pharma Inc. (TSX:VPH, OTCQB:VPHIF) CEO Steve Saviuk joined Proactive's Stephen Gunnion to discuss the company's strong position on the Globe and Mail's Report on Business annual list of Canada’s top-growing companies. The company placed 151 out of 425, with a...
(NewsDirect) Valeo Pharma Inc. (TSX:VPH, OTCQB:VPHIF) CEO Steve Saviuk joined Proactive's Stephen Gunnion to discuss the company's strong position on the Globe and Mail's Report on Business annual list of Canada’s top-growing companies. The company placed 151 out of 425 com...
VALEO PHARMA MAKES THE LIST OF THE GLOBE AND MAIL'S FIFTH-ANNUAL RANKING OF CANADA'S TOP GROWING COMPANIES Canada NewsWire MONTREAL , Oct. 4, 2023 /CNW/ - Valeo Pharma Inc . (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " or the " Company "), a Canadi...
(NewsDirect) Valeo Pharma CEO Steve Saviuk joined Steve Darling from Proactive to share details the company has entered into a credit facility agreement with Accord Financial for a total of $5 million. The credit facility, backed by a first-ranking lien on the company's short-term ass...
VALEO PHARMA ENTERS INTO $5 MILLION CREDIT FACILITY AGREEMENT WITH ACCORD FINANCIAL INC. Canada NewsWire MONTREAL , Sept. 27, 2023 /CNW/ - Valeo Pharma Inc . (TSX: VPH) (OTCQB: VPHIF) (FSE:VP2) (" Valeo " or the " Company "), a Canadian pharmaceu...
(NewsDirect) Valeo Pharma CEO Steve Saviuk joined Proactive's Steve Darling to share news regarding the company's strong third-quarter performance. The company has once again shattered its own records, demonstrating remarkable growth in various key areas of its business. In 3Q 202...
VALEO PHARMA REPORTS RECORD THIRD QUARTER 2023 REVENUES Canada NewsWire Seventh consecutive quarter of revenue growth at $14.1 million in Q3-23, up 132% over Q3-22. Physicians prescribing Enerzair and Atectura reached 2,503 at the end of Q3-23, representing a 23%...
News, Short Squeeze, Breakout and More Instantly...
Valeo Pharma Company Name:
VPHIF Stock Symbol:
OTCMKTS Market:
VALEO PHARMA ANNOUNCES RESULTS OF ANNUAL MEETING OF SHAREHOLDERS Canada NewsWire MONTREAL , April 25, 2024 /CNW/ - Valeo Pharma Inc . (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " or the " Company "), a Canadian pharmaceutical company, today announc...
VALEO PHARMA TO PRESENT AT THE 2024 BLOOM BURTON & CO HEALTHCARE INVESTOR CONFERENCE VALEO PHARMA TO PRESENT AT THE 2024 BLOOM BURTON & CO HEALTHCARE INVESTOR CONFERENCE Canada NewsWire MONTREAL , April 9, 2024 /CNW/ - Valeo Pharma Inc . (TSX: VPH) (OTCQB...
VALEO PHARMA ANNOUNCES APPOINTMENT OF MR. AL MOGHADDAM TO BOARD OF DIRECTORS Canada NewsWire MONTREAL , March 22, 2024 /CNW/ - Valeo Pharma Inc . (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " or the " Company "), a Canadian pharmaceutical company, t...